Cover Image

AAV-based gene replacement: The promise of gene therapy for deafness

Saved in:

Bibliographic Details
Main Authors:	Jieyu Qi (Author), Liyan Zhang (Author), Renjie Chai (Author)
Format:	Book
Published:	Elsevier, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

AAV gene therapy vectors in the TMJ
by: Sabine M. Brouxhon, et al.
Published: (2022)

Effective AAV-mediated gene replacement therapy in retinal organoids modeling AIPL1-associated LCA4
by: Hali Sai, et al.
Published: (2024)

AAV-regulated Serpine2 overexpression promotes hair cell regeneration
by: Qiuhan Sun, et al.
Published: (2024)

Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy
by: Anne Louise Askou, et al.
Published: (2019)

An AAV-Based NF-κB-Targeting Gene Therapy (rAAV-DMP-miR533) to Inflammatory Diseases
by: Luo T, et al.
Published: (2022)

Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy
by: Arun Srivastava
Published: (2023)

Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy
by: Shin'ichi Takeda, et al.
Published: (2013)

Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques
by: Liam Cole, et al.
Published: (2021)

Rapamycin immune tolerization enables gene transfer following subcutaneous delivery of AAV6 but not CD4-retargeted AAV6 vectors in AAV-seropositive rhesus macaques
by: K. Jerome, et al.
Published: (2019)

AAV-based gene editing of type 1 collagen mutation to treat osteogenesis imperfecta
by: Yeon-Suk Yang, et al.
Published: (2024)

Gene Therapy in the Light of Lifestyle Diseases: Budesonide, Acetaminophen and Simvastatin Modulates rAAV Transduction Efficiency
by: Żaneta Słyk, et al.
Published: (2024)

Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy
by: Sergio Muñoz, et al.
Published: (2024)

OP 6.5 - 00164 Nanobody-engineered AAV vectors for CD4-targeted gene therapy
by: U. Lange, et al.
Published: (2022)

The Signalling Role of the avβ5-Integrin Can Impact the Efficacy of AAV in Retinal Gene Therapy
by: Jean Bennett, et al.
Published: (2012)

Controlled Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy
by: Fernando Alvarez-Rivera, et al.
Published: (2020)

AAV1.NT‐3 gene therapy in the SOD1KO mouse model of accelerated sarcopenia
by: Lingying Tong, et al.
Published: (2023)

Enhanced Transduction of Human Hematopoietic Stem Cells by AAV6 Vectors: Implications in Gene Therapy and Genome Editing
by: Hua Yang, et al.
Published: (2020)

BB-301: a silence and replace AAV-based vector for the treatment of oculopharyngeal muscular dystrophy
by: Vanessa Strings-Ufombah, et al.
Published: (2021)

CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
by: Wei-Jing Dai, et al.
Published: (2016)

Replacing daily cART with AAV-expressed eCD4-Ig
by: M. Gardner, et al.
Published: (2019)

Flexible, AAV-equipped Genetic Modules for Inducible Control of Gene Expression in Mammalian Brain
by: Godwin K Dogbevia, et al.
Published: (2016)

Next Step in Gene Delivery: Modern Approaches and Further Perspectives of AAV Tropism Modification
by: Maxim A. Korneyenkov, et al.
Published: (2021)

Fetal Brain-directed AAV Gene Therapy Results in Rapid, Robust, and Persistent Transduction of Mouse Choroid Plexus Epithelia
by: Marie Reine Haddad, et al.
Published: (2013)

E-Selectin/AAV Gene Therapy Promotes Myogenesis and Skeletal Muscle Recovery in a Mouse Hindlimb Ischemia Model
by: Antoine J. Ribieras, et al.
Published: (2023)

Gene therapies development: slow progress and promising prospect
by: Eve Hanna, et al.
Published: (2017)

CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector
by: Giridhar Murlidharan, et al.
Published: (2016)

Optimized AAV rh.10 Vectors That Partially Evade Neutralizing Antibodies during Hepatic Gene Transfer
by: Ruchita Selot, et al.
Published: (2017)

Gene Therapy, Early Promises, Subsequent Problems, and Recent Breakthroughs
by: Saeideh Razi Soofiyani, et al.
Published: (2013)

Gene therapy: a promising approach for neuroprotection in Parkinson's disease?
by: Pamela Valdés, et al.
Published: (2016)

Gene replacement therapy in spinal muscular atrophy: filling the data gaps
by: Tim Hagenacker, et al.
Published: (2024)

Health economic evaluation of gene replacement therapies: methodological issues and recommendations
by: Samuel Aballéa, et al.
Published: (2020)

LinQURE: A novel AAV gene silencing platform that supports multi-transcript targeting for complex disorders
by: Irena Bočkaj, et al.
Published: (2024)

Commentary: Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?
by: Juan Segura-Aguilar
Published: (2017)

A pan-cancer study of selenoprotein genes as promising targets for cancer therapy
by: Wentao Wu, et al.
Published: (2021)

AAV-aMTD-Parkin, a therapeutic gene delivery cargo, enhances motor and cognitive functions in Parkinson's and Alzheimer's diseases
by: Seokwon Lee, et al.
Published: (2024)

In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury
by: Miri Kim, et al.
Published: (2024)

Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes
by: Dzerassa Gurtsieva, et al.
Published: (2024)

"Deafness -Associated Connexin 26 Gene (GJB2) Mutations in Iranian Population"
by: M Hashemzadeh Chaleshtori, et al.
Published: (2002)

"Deafness -Associated Connexin 26 Gene (GJB2) Mutations in Iranian Population"
by: M Hashemzadeh Chaleshtori, et al.
Published: (2002)

Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation
by: Seung Ryul Han, et al.
Published: (2021)